The Healthcare Technology Report is pleased to announce The Top 25 MedTech Companies of 2025. MedTech is at the forefront of the healthcare revolution, transforming how we approach patient care. From robotic systems that provide unprecedented precision in surgery to AI-driven tools that enable faster, more accurate diagnoses, these companies are reshaping medical practices. Their innovations are creating a future where high-quality healthcare is more accessible, efficient, and safer for patients around the world.
The companies featured in this list are addressing some of the most critical challenges in healthcare today. As healthcare systems face growing demands, they are developing solutions that improve treatment affordability, reduce surgical risks, and accelerate recovery times. Through innovations like minimally invasive procedures, AI-powered diagnostics, and non-invasive therapies, they are making significant strides in improving patient outcomes and creating more efficient care pathways. Their work is driving lasting change, advancing the way healthcare is delivered and making it more accessible to a global population.
Among this year’s awardees, SMC is reshaping the healthcare manufacturing landscape with its focus on single-use, single-patient devices, driving efficiency and speed-to-market while maintaining the highest quality standards. Additionally, ROMTech is revolutionizing orthopedic recovery with its innovative PortableConnect® device, enabling patients to recover up to 50% faster, reducing costs and improving patient outcomes. Sartorius, a key player in life sciences and biopharmaceutical manufacturing, is accelerating drug development and improving manufacturing efficiency, empowering global healthcare advancements and helping bring biotech drugs and advanced therapies to market. Together, these companies are improving healthcare by streamlining manufacturing, accelerating recovery, and advancing drug development to enhance patient care.
The recipients of this year’s award were selected based on a comprehensive evaluation of each company’s contributions to advancing medical technology and their tangible impact on improving patient care and healthcare delivery. Please join us in celebrating The Top 25 MedTech Companies of 2025.
1. CMR Surgical
CMR Surgical is a global medical devices company aiming to revolutionize the field of minimally invasive surgery with Versius®, its next-generation surgical robotic system. Headquartered in Cambridge, UK, CMR is committed to making robotic-assisted minimally invasive surgery universally accessible and affordable. Since its founding in 2014, the company has grown rapidly, driven by the mission to redefine the surgical robotics market with practical, innovative technology.
Versius® empowers surgeons to perform complex procedures with precision, flexibility, and adaptability, improving both surgical outcomes and patient care. The system’s design, which biomimics the human arm, allows for a range of motion, 3D HD vision, and small, fully-wristed instruments for greater dexterity during surgery.
As the first robotic system for use in cholecystectomy to receive U.S. FDA Marketing Authorization through the De Novo application process, Versius® has proven its effectiveness in routine clinical practice, supporting surgeons in delivering high-quality care. CMR’s patient-focused approach goes beyond product development, fostering strong partnerships with surgeons, surgical teams, and hospitals to integrate Versius® seamlessly into existing workflows.
The company also recently announced the successful closing of a financing round totaling over $200 million through a combination of equity and debt capital, enabling CMR to scale its mission globally. Through its innovation, training support, and commitment to improving surgical care, CMR Surgical aims to transform how surgery is performed worldwide.
2. Norstella
Norstella is a global pharmaceutical intelligence company dedicated to accelerating access to life-saving therapies. Formed by the integration of market-leading companies—Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group—Norstella delivers a comprehensive suite of clinical, commercial, and consultancy solutions that guide life sciences organizations through every stage of the drug development journey, from pipeline to patient.
Norstella equips its clients with the insights and tools needed to navigate regulatory complexity, optimize market access, and drive evidence-based decision-making. Recently, Norstella’s LinQ data source was added to the Atropos Evidence™ Network, ranking in the top decile for data quality according to the Real World Fitness Score®. This reinforces Norstella’s position at the forefront of real-world data solutions for claims-based research and evidence generation.
3. Zeiss Medical Technology
ZEISS is a globally leading technology enterprise operating in the optics and optoelectronics industries. The Carl Zeiss Meditec branch of the company was founded in 2002 and is rooted in a legacy of scientific excellence, innovation, and social responsibility. The company is committed to improving healthcare outcomes, investing heavily in research and development to advance technologies that help shape the future of medicine.
One of ZEISS's recent advancements includes the Intrabeam 700 platform, which received FDA 510(k) clearance for robotic-assisted intraoperative radiation therapy. This system improves precision and efficiency in the treatment of neuro-oncology and breast cancer.
In ophthalmology, ZEISS introduced the ZEISS Research Data Platform (RDP), a cloud-based, AI-driven solution designed to accelerate discoveries and enhance personalized care. The platform integrates clinical and research data to support the development of innovative treatments for retinal diseases, in collaboration with industry leaders like Boehringer Ingelheim. Through these efforts, ZEISS is making significant strides in improving diagnostic capabilities and treatment precision.
4. Mölnlycke Health Care
Mölnlycke Health Care is a global medical technology company based in Sweden, delivering advanced solutions in wound care and surgical procedures across more than 100 countries. Founded in 1849, the company addresses urgent healthcare challenges through products designed to reduce infection, speed up healing, and enhance surgical efficiency while lowering the burden on healthcare workers and minimizing environmental impact. The company recently achieved a significant milestone by securing 100% renewable electricity for its manufacturing sites and headquarters, furthering its commitment to halve Scope 1 and 2 greenhouse gas emissions by 2030.
Operating in four key areas—wound care, operating room solutions, gloves, and antiseptics—Mölnlycke continues to innovate with products that improve patient outcomes and support healthcare professionals. With a focus on advancing healthcare performance, the company develops innovative, evidence-based solutions designed to improve both clinical outcomes and financial efficiency. By listening to the needs of healthcare professionals, Mölnlycke tailors its products to enhance patient care while offering value for money.
5. Medline Industries
Medline is a provider of medical-surgical products and supply chain solutions, serving all points of care. The company offers a comprehensive portfolio of approximately 335,000 medical products and specializes in improving clinical, financial, and operational outcomes.
Headquartered in Northfield, Illinois, Medline employs over 43,000 people globally and operates in more than 100 countries and territories. The company combines world-class products with supply chain resilience and clinical practice expertise, ensuring it delivers exceptional value across healthcare sectors. Medline’s integrated solutions support healthcare providers in optimizing operations while improving patient care outcomes.
In addition to its ongoing innovations in healthcare, Medline recently filed confidentially for a proposed initial public offering (IPO) in 2025, potentially raising more than $5 billion. This move could value the company at approximately $50 billion, marking a significant milestone in its expansion and continued leadership in the healthcare supply chain industry.
6. ROMTech
ROM Technologies Inc. (ROMTech), founded in 2013 and based in Brookfield, Connecticut, is a leading innovator in orthopedic rehabilitation. The company offers a patented, breakthrough technology that enables knee and hip surgery patients to recover up to 50% faster. Designed for in-home use, the company’s flagship device, the PortableConnect®, empowers patients to complete therapy safely and efficiently from the comfort of their own home. The telehealth rehabilitation system has rapidly expanded its reach, now serving over 90,000 patients nationwide across both orthopedic and cardiac care. In the first half of 2024 alone, ROMTech facilitated rehabilitation for more than 25,000 patients, a significant increase from previous years.
ROMTech’s advanced telemedicine platform supports recovery from total knee and hip replacements, ACL injuries, joint manipulations, and other arthroscopic procedures—delivering faster outcomes, improved pain management, and lower costs for patients, providers, and payors alike. With strong adoption from physicians nationwide and a growing footprint in post-operative care, ROMTech aims to reshape the future of orthopedic recovery through remote connectivity, enhanced diagnostics, and patient-centered innovation.
7. Abbott Laboratories
Abbott is a global healthcare leader dedicated to helping people live more fully through every stage of life. With a diverse portfolio spanning diagnostics, medical devices, nutritionals, and branded generic medicines, Abbott delivers technologies that support healthier lives worldwide. For over 135 years, Abbott has been at the forefront of healthcare innovation, focusing on improving cardiovascular health, managing diabetes, advancing diagnostic capabilities, providing neuromodulation therapies, and offering nutritional support. Abbott's commitment to improving outcomes for individuals at every stage of life drives its global reach, with the company operating in more than 160 countries and employing 114,000 people.
Most recently, Abbott received FDA approval for Tendyne™, the first transcatheter mitral valve replacement device that does not require open-heart surgery—marking another major milestone in advancing minimally invasive cardiac care. Abbott’s broad range of life-changing technologies, including innovations in glucose monitoring, chronic pain management, and nutrition, helps patients and healthcare providers worldwide make informed decisions and improve health outcomes.
8. Siemens Healthineers
Siemens Healthineers is a global leader in healthcare equipment, solutions, and services, operating in over 180 countries with direct representation in more than 70. As a pioneering medical technology company, Siemens Healthineers is dedicated to improving healthcare access for underserved communities and addressing some of the most pressing diseases. The company’s portfolio spans imaging, diagnostics, cancer care, and minimally invasive therapies, and is further enhanced by digital technology and artificial intelligence.
The company is committed to advancing healthcare through innovation and sustainability, aiming to improve clinical outcomes and expand access to quality care globally. Siemens Healthineers offers a wide range of advanced imaging technologies for cancer screening, including MRI, CT, and PET/CT systems. These imaging technologies provide high-quality images that help physicians identify cancer at its earliest stages, when treatment is most effective. Furthermore, their software solutions offer powerful tools for image analysis and reporting to support accurate and efficient diagnoses. With a global workforce of approximately 72,000 employees, Siemens Healthineers is continually working toward its mission to improve healthcare access.
9. bioMérieux
bioMérieux is a family-owned global company specializing in in vitro diagnostics, driven by a century-long entrepreneurial spirit and a mission to improve public health. Since 1963, the company has been at the forefront of diagnostic innovation, delivering solutions that empower healthcare professionals and industry stakeholders to make confident, timely decisions that improve patient outcomes and safeguard consumer health. bioMérieux's portfolio includes systems, reagents, software, and services designed to determine the source of disease and contamination, ensuring patient safety and improving public health outcomes.
Among their recent innovations is the GENE-UP® TYPER, a real-time PCR solution that enables rapid pathogen detection and root cause analysis in industries such as food safety. This cutting-edge technology helps food manufacturers quickly identify contamination sources, minimizing health risks and reducing costly recalls. By using machine learning to analyze microbial strains, bioMérieux's solutions streamline decision-making processes, making them critical tools in both healthcare and industrial applications. With a global presence in 45 countries, bioMérieux continues to lead the way in diagnostics, helping ensure safer, healthier lives worldwide.
10. Sartorius
Sartorius is a leading international partner for life sciences research and biopharmaceutical manufacturing. Headquartered in Göttingen, Germany, the company supports its global customers in developing and producing medications safely, efficiently, and cost-effectively. With a strong presence across approximately 60 production and sales sites worldwide, Sartorius plays a vital role in advancing healthcare by accelerating the transition from scientific discovery to patient care.
Operating in two core divisions—lab products and services and bioprocess solutions—Sartorius delivers innovative laboratory instruments, consumables, and single-use technologies that serve pharmaceutical and biopharmaceutical companies, as well as academic institutions. In the medtech space, Sartorius provides critical solutions for quality control, including precision weighing systems, microbial testing, and aseptic connection systems.
The company’s technologies support the production of high-quality medical devices, ensuring sterility, safety, and regulatory compliance throughout manufacturing. Its solutions are key to the production of biotech drugs, vaccines, and advanced therapies such as cell and gene treatments. With over 13,500 employees representing more than 110 nations, Sartorius is united by a common goal: improving global health by enabling faster, more efficient drug development and manufacturing.
11. Xenco Medical
Xenco Medical is a medical technology company that designs, develops, and distributes composite polymer medical devices. Developed through extensive research at the intersection of materials science and biomechanical engineering, Xenco Medical’s SETx Technology eliminates the expensive, cumbersome, and inefficient processes necessary for traditional implant systems.
SETx Technology ensures each surgery is conducted with single-use implant systems, which are sterile, ready for use, and perform at their peak. This patient-specific approach reduces the risk of infection and cross-contamination, unlike traditional systems that are reused across multiple patients. The intuitive design of the devices improves operating room efficiency, reducing time spent on preparation and minimizing inventory management challenges.
Xenco Medical is also advancing regenerative medicine with its innovative approach to spinal and orthopedic surgery. The company’s TrabeculeX Continuum technology combines biomaterial implants and AI-driven digital health rehabilitation to enhance bone regeneration after surgery. By integrating regenerative medicine with cutting-edge digital health tools, Xenco Medical is reshaping the future of orthopedic recovery and improving patient care.
12. SMC
SMC focuses exclusively on contract manufacturing for the healthcare industry. Established in 1988 with the purpose of manufacturing high-quality products more rapidly than other manufacturers of the day, the company has retained this core value of speed-to-market. It has helped the company grow into a globally recognized contract manufacturer specializing in single-use and single-patient medical, drug delivery, and diagnostic devices.
Still privately owned, SMC offers customers agile decision-making and true strategic partnership. Its specialized, experienced teams drive efficiency, scalability, and risk reduction at each stage of a project, to make sure timelines are met.
SMC provides full-service medical manufacturing for the pharmaceutical, medtech, and diagnostics markets. Its focus is on single-use and single-patient finished devices. With its long history of quality and partnerships with leading companies in all three markets, SMC understands the complex medical manufacturing ecosystem.
13. SprintRay
SprintRay is a leading manufacturer of 3D printing solutions, focused exclusively on advancing digital dentistry. Since its founding in 2014, the company has delivered a portfolio of user-friendly, high-performance products designed to enable in-office manufacturing and empower dental professionals to expand treatment capabilities, reduce turnaround times, and enhance patient care.
Built in close collaboration with dental experts, designers, and engineers, SprintRay’s workflow-driven ecosystem—including design software, proprietary materials, and advanced 3D printers—is engineered to maximize clinical efficiency and reliability. The company’s mission is to make 3D printing technology accessible, intuitive, and transformative for dental practices worldwide.
SprintRay operates with a customer-centric, agile, and innovation-driven culture. By challenging assumptions and relentlessly solving problems, the organization aims to redefine digital dentistry standards. Its commitment to quality and deep connection to the dental community drive the development of targeted solutions that address the industry's most urgent needs.
14. Cala Health
Cala Health is a bioelectronic medicine company redefining chronic disease management through wearable neuromodulation therapies. By combining advances in neuroscience and technology, Cala delivers individualized peripheral nerve stimulation to treat chronic conditions with precision and without surgery or drugs.
The company’s lead therapy targets essential tremor, a neurological disorder affecting over 7 million people and marked by disruptive hand tremors. Cala’s non-invasive, prescription-based device offers patients a new standard of care—one that restores function and confidence. The latest generation of this technology, Cala kIQ, represents the company’s most advanced solution, built on years of clinical refinement and patient feedback.
Headquartered in the San Francisco Bay Area, Cala Health is expanding its therapeutic pipeline across neurology, cardiology, and psychiatry. The company recently raised $50 million in a growth round to accelerate the commercialization of its TAPS therapy for essential tremor, expanding access to patients, including Medicare beneficiaries, and enhancing its visibility among healthcare providers. With a mission to transform the standard of care for people living with essential tremor, Cala Health is supported by its strong investor base as it continues to lead innovation in wearable neuromodulation therapy.
15. OrganOx
OrganOx is a leader in organ preservation technology, aiming to transform the field of liver transplantation through its patented normothermic machine perfusion system. The company’s flagship product, the OrganOx metra®, enables the preservation of donor livers in a functioning, warm state for up to 24 hours prior to transplantation, offering a significant advancement over traditional cold storage methods. In fact, clinical evidence shows that the metra® reduces organ discard rates by 50% and enables 20% more liver transplants compared to static cold storage.
Developed from research led by Professor Peter Friend and colleagues, OrganOx has been at the forefront of the normothermic perfusion movement since its first publication in 2002. Backed by over 50 scientific publications, the metra® has supported more than 2,000 liver transplants worldwide, helping to increase organ utilization and improve transplant outcomes. By allowing clinicians to assess organ viability in real time, OrganOx aims to redefine donor liver preservation and expand access to life-saving transplants.
16. HistoSonics
HistoSonics is a venture-backed medical device company developing a non-invasive therapy platform based on the science of histotripsy. This proprietary technology uses focused sound energy to generate controlled acoustic pressure, mechanically destroying targeted tissue—such as tumors, at a sub-cellular level without the need for incisions, radiation, or heat. HistoSonics is led by a team of seasoned experts in medical technology, clinical development, and commercialization and is redefining tissue treatment through innovation in focused sound energy, aiming to set a new standard in non-invasive care.
The company offers personalized, tissue-specific treatments with high precision and minimal side effects, representing a major advancement over traditional surgical and interventional approaches. Initially focused on the treatment of liver tumors, HistoSonics is working to expand its applications across multiple disease areas.
HistoSonics’ Edison system for non-invasive destruction of liver tumors recently gained early market access in the UK under the Innovative Devices Access Pathway (IDAP) program. Following FDA De Novo clearance in 2023, the Edison system has been adopted by major academic centers and hospitals across the U.S., marking a significant milestone in expanding the use of histotripsy.
17. Ceribell
Ceribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting.
By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated AI-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA 510(k) cleared for indicating suspected seizure activity and is currently utilized in intensive care units and emergency rooms across the U.S.
Ceribell has recently expanded its coverage to include pediatric patients with the FDA-cleared Clarity™ Algorithm, marking a significant step in providing seizure detection technology across a larger age range. Headquartered in Sunnyvale, California, Ceribell's mission is to establish its system as the standard of care for EEG in acute care settings, ultimately helping clinicians save patient lives.
18. Magenta Medical
Magenta Medical is a medical device company developing advanced mechanical circulatory support solutions using its proprietary technology platform of miniaturized, catheter-mounted axial flow pumps. At the core of Magenta’s innovation are self-expanding impellers and pump heads, enabling the creation of highly compact, yet powerful, circulatory support devices.
The company’s flagship product is a percutaneous Left Ventricular Assist Device (pLVAD) designed for temporary use in patients undergoing high-risk coronary interventions or suffering from cardiogenic shock. The arterial pump features a low-profile design that allows for easier deployment and improved patient outcomes compared to existing technologies.
In June 2024, Magenta closed a $105 million financing round to support its U.S. clinical programs and advance the Elevate™ System—the world’s smallest heart pump. This breakthrough technology has received Breakthrough Device Designation from the FDA for two clinical indications: high-risk percutaneous coronary intervention (HR-PCI) and cardiogenic shock.
By combining miniaturization with high performance, Magenta is aiming to redefine standards in mechanical circulatory support, offering clinicians new tools to stabilize and treat critically ill cardiac patients with speed, precision, and less invasiveness.
19. Olympus
Olympus is a global medical technology company committed to making lives healthier, safer, and more fulfilling. With a heritage of over 100 years, the company partners with healthcare professionals to deliver innovative, customer-driven solutions for early detection, diagnosis, and minimally invasive treatment. Olympus is dedicated to improving patient outcomes by raising the standard of care across targeted disease areas.
The company offers a wide range of medical technologies, including endoscopic solutions such as endoscopes, laparoscopes, and video imaging systems. Olympus also provides therapeutic solutions, offering endotherapy instruments that help prevent, detect, and treat disease. With a focus on delivering advanced diagnostic, therapeutic, and minimally invasive procedures, Olympus helps healthcare professionals improve clinical outcomes, reduce costs, and enhance the quality of life for patients.
Headquartered in Tokyo, Japan, Olympus operates in nearly 40 countries and regions, employing more than 31,000 people worldwide. The company’s technologies support the prevention, diagnosis, and treatment of disease, advance scientific research, and contribute to public safety, reinforcing its long-standing mission to serve society through purposeful innovation.
20. CONMED Corporation
CONMED is a global medical technology company focused on developing and delivering surgical and patient monitoring solutions that enable healthcare providers to achieve exceptional clinical outcomes. With a strong presence across multiple specialties—including orthopedics, laparoscopic, robotic and open surgery, gastroenterology and pulmonology, and cardiology and critical care—CONMED products are recognized worldwide for their innovation, quality, and performance.
CONMED’s product portfolio includes the BioBrace® Reinforced BioInductive Implant for soft tissue augmentation, the AirSeal® insufflation system for low-pressure surgery, and a wide range of smoke evacuation systems, ensuring safer environments for healthcare providers and patients.
Headquartered in Largo, Florida, CONMED employs approximately 3,500 people across manufacturing, distribution, design, and sales facilities throughout the United States and in over 20 international locations. The company’s mission is to make advanced healthcare solutions accessible to providers globally, empowering them to deliver high-quality patient care.
21. Össur
Össur is a provider of non-invasive mobility solutions, dedicated to helping individuals live more freely. Founded in 1971 as an orthotic and prosthetic (O&P) clinic, the company has grown into a trusted provider of prosthetics and bracing and supports, delivering high-quality patient care through an extensive network of clinical facilities.
With a strong focus on innovation, Össur has secured over 2,000 patents and developed technologies that drive successful clinical outcomes and reinforce its strong position in the market. The company’s product offerings include advanced prosthetic devices, such as the Össur Proprio Foot®, which uses microprocessors to adjust the foot's position for enhanced comfort and stability, and the Össur Rheo Knee®, a powered knee prosthesis designed to improve mobility and safety for users.
Össur operates in 36 countries and employs approximately 4,000 people. As a signatory to the UN Global Compact and UN Women’s Empowerment Principles, and a contributor to the UN Sustainable Development Goals, Össur is committed to responsible business practices and environmental sustainability. The company has pledged to achieve Net Zero emissions by 2050 through the Science Based Targets initiative.
22. Terumo
Terumo is a medical technology company with over a century of experience in advancing healthcare. Headquartered in Tokyo, the company operates in more than 160 countries and employs over 30,000 associates worldwide. Originally established as a Japanese thermometer manufacturer, Terumo has evolved into a diversified healthcare company. Its broad portfolio includes vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technologies, and essential medical products used in everyday clinical practice.
In vascular intervention, Terumo offers solutions like the ANGIO-SEAL® VIP Vascular Closure Device and AZUR® Peripheral HydroCoil Embolization System to seal puncture sites and embolize blood vessels. For cardio-surgical procedures, the company provides heart-lung machines and perfusion circuits to temporarily support heart and lung function. In blood transfusion and cell therapy, Terumo develops systems for red blood cell exchange and cell collection, supporting treatments for conditions like sickle cell disease and stem cell transplants.
With a focus on research, development, manufacturing, and distribution, Terumo delivers innovative products and services that address the needs of both patients and healthcare professionals, contributing to the advancement of global medical technology.
23. Heartflow
Heartflow is a medical technology company specializing in AI-powered, non-invasive solutions for precision coronary care within the Coronary Computed Tomography Angiography (CCTA) pathway. The company is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition. As the creator of Fractional Flow Reserve Computed Tomography (FFRCT), endorsed by the American College of Cardiology and the American Heart Association, Heartflow is improving the diagnosis and management of coronary artery disease, the leading cause of death globally.
Heartflow aims to transform the management of CAD, making it screenable and diagnosable. Heartflow One is the only complete, non-invasive platform providing insights across the CCTA pathway. The AI-driven platform, including RoadMap™ Analysis, FFRCT Analysis, and Plaque Analysis, is supported by the ACC/AHA Chest Pain Guideline and more than 600 peer-reviewed publications. By leveraging cutting-edge AI technology, the company has helped manage the care of over 400,000 patients worldwide, enabling clinicians to deliver real-time, actionable insights that result in improved patient outcomes.
24. Dornier MedTech
Dornier MedTech is a leading medical device company specializing in urological care, headquartered near Munich, Germany, and operating as a wholly owned subsidiary of Advanced MedTech. Recognized as a pioneer in shockwave lithotripsy and a trusted name in the industry, Dornier continues to drive innovation through its high-quality urological technologies.
With a strong foundation in entrepreneurship and clinical excellence, Dornier has expanded its offerings to include advanced laser systems and a comprehensive range of consumables. These advanced laser systems, including the Dornier Thulio®, enhance precision in treating urological conditions, such as urinary stones and benign prostatic hyperplasia, through effective stone fragmentation and soft tissue treatment. These developments enhance clinical outcomes and reflect the company's commitment to advancing endourology.
As the world’s first MDR-certified integrated urology company and a founding member of the Urology Care Foundation, Dornier upholds the highest standards of safety and efficacy. The company is also at the forefront of digital urology, offering holistic solutions that support patients both online and in-person throughout their treatment and recovery.
25. CIVCO Medical Solutions
CIVCO Medical Solutions is a leader in designing, manufacturing, and marketing products that enhance the safety of image-guided procedures. Founded in 1981, CIVCO has built a strong reputation for innovation and exceptional service, with a presence in over 100 countries and partnerships with leading ultrasound manufacturers worldwide.
CIVCO’s product line includes ultrasound probe covers, needle guides, and disinfection solutions, all designed to protect equipment and enhance clinical outcomes. Their products also include systems for ultrasound-guided transperineal and transrectal procedures, as well as electromagnetic needle tracking and fusion auto-registration solutions, improving the precision and safety of interventions. The company’s growth has been marked by strategic expansions, including the 2016 acquisition of PCI Medical, a manufacturer specializing in ultrasound and endoscope reprocessing solutions.
Headquartered in Iowa, CIVCO employs nearly 200 associates globally and operates as a subsidiary of Roper Technologies. Beyond product innovation, CIVCO is committed to making a positive impact in healthcare and within the communities it serves.
